Cyclo Therapeutics CYTH Stock
Cyclo Therapeutics Price Chart
Cyclo Therapeutics CYTH Financial and Trading Overview
| Cyclo Therapeutics stock price | 1.26 USD |
| Previous Close | 2.1 USD |
| Open | 2 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 1.97 - 2.23 USD |
| 52 Week Range | 0.67 - 2.75 USD |
| Volume | 83.8K USD |
| Avg. Volume | 162.26K USD |
| Market Cap | 31.7M USD |
| Beta (5Y Monthly) | -0.424295 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5 USD |
CYTH Valuation Measures
| Enterprise Value | 30.99M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.9904763 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 23.777649 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 23.245 |
| Enterprise Value/EBITDA | -1.753 |
Trading Information
Cyclo Therapeutics Stock Price History
| Beta (5Y Monthly) | -0.424295 |
| 52-Week Change | -6.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.75 USD |
| 52 Week Low | 0.67 USD |
| 50-Day Moving Average | 1.18 USD |
| 200-Day Moving Average | 1.49 USD |
CYTH Share Statistics
| Avg. Volume (3 month) | 162.26K USD |
| Avg. Daily Volume (10-Days) | 239.65K USD |
| Shares Outstanding | 15.17M |
| Float | 11.3M |
| Short Ratio | 0.62 |
| % Held by Insiders | 11.22% |
| % Held by Institutions | 12.59% |
| Shares Short | 61.69K |
| Short % of Float | 0.44% |
| Short % of Shares Outstanding | 0.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1327.15% |
| Gross Margin | 89.45% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -110.47% |
| Return on Equity (ttm) | -280.53% |
Income Statement
| Revenue (ttm) | 1.33M USD |
| Revenue Per Share (ttm) | 0.15 USD |
| Quarterly Revenue Growth (yoy) | -21.80% |
| Gross Profit (ttm) | 1.23M USD |
| EBITDA | -17675002 USD |
| Net Income Avi to Common (ttm) | -17686382 USD |
| Diluted EPS (ttm) | -1.79 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 915.18K USD |
| Total Cash Per Share (mrq) | 0.06 USD |
| Total Debt (mrq) | 53.5K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.888 |
| Book Value Per Share (mrq) | -0.044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14654231 USD |
| Levered Free Cash Flow (ttm) | -7998127 USD |
Profile of Cyclo Therapeutics
| Country | United States |
| State | FL |
| City | Gainesville |
| Address | 6714 NW 16th Street |
| ZIP | 32653 |
| Phone | 386 418 8060 |
| Website | https://cyclotherapeutics.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Q&A For Cyclo Therapeutics Stock
What is a current CYTH stock price?
Cyclo Therapeutics CYTH stock price today per share is 1.26 USD.
How to purchase Cyclo Therapeutics stock?
You can buy CYTH shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cyclo Therapeutics?
The stock symbol or ticker of Cyclo Therapeutics is CYTH.
Which industry does the Cyclo Therapeutics company belong to?
The Cyclo Therapeutics industry is Drug Manufacturers-Specialty & Generic.
How many shares does Cyclo Therapeutics have in circulation?
The max supply of Cyclo Therapeutics shares is 28.72M.
What is Cyclo Therapeutics Price to Earnings Ratio (PE Ratio)?
Cyclo Therapeutics PE Ratio is now.
What was Cyclo Therapeutics earnings per share over the trailing 12 months (TTM)?
Cyclo Therapeutics EPS is -1.23 USD over the trailing 12 months.
Which sector does the Cyclo Therapeutics company belong to?
The Cyclo Therapeutics sector is Healthcare.
Cyclo Therapeutics CYTH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}